BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36240652)

  • 1. Aerobic exercise improves intestinal mucosal barrier dysfunction through TLR4/MyD88/NF-κB signaling pathway in diabetic rats.
    Li J; Liu X; Wu Y; Ji W; Tian Q; Li S
    Biochem Biophys Res Commun; 2022 Dec; 634():75-82. PubMed ID: 36240652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of moxibustion on intestinal barrier function and TLR4/NF-κB p65 signaling pathway in obese rats.
    Chen X; Zhang Y; Huang W; Zhang Y; Kong W; Zhou Z
    Zhongguo Zhen Jiu; 2024 Apr; 44(4):449-454. PubMed ID: 38621733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TLR4/MyD88/NF-κB in the protective effect of ulinastatin on the intestinal mucosal barrier in mice with sepsis.
    Wenying S; Jing H; Ying L; Hui D
    BMC Anesthesiol; 2023 Dec; 23(1):414. PubMed ID: 38102579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
    Yang Y; Sheng Y; Wang J; Zhou X; Guan Q; Shen H; Li W; Ruan S
    J Cell Mol Med; 2021 Aug; 25(15):7257-7269. PubMed ID: 34184406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroacupuncture restores intestinal mucosal barrier through TLR4/NF-κB p65 pathway in functional dyspepsia-like rats.
    Wang D; Zhang J; Yang D; Wang J; Li J; Han Y; Kang Z; Zhang H
    Anat Rec (Hoboken); 2023 Dec; 306(12):2927-2938. PubMed ID: 34713984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic exposure induces small intestinal toxicity in mice by barrier damage and inflammation response via activating RhoA/ROCK and TLR4/Myd88/NF-κB signaling pathways.
    Zhao D; Jiao S; Yi H
    Toxicol Lett; 2023 Aug; 384():44-51. PubMed ID: 37442281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of Fushen Granules treat peritoneal dialysis-related peritonitis by regulating TLR4/NF-κB pathway:based on network pharmacology and animal experiments].
    Xing HT; Ding FM; Li JQ; Zhou QY; Yang HT
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1621-1631. PubMed ID: 38621947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Gut Microflora by
    Li Y; Zhao L; Sun C; Yang J; Zhang X; Dou S; Hua Q; Ma A; Cai J
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharides from Acanthopanax senticosus enhances intestinal integrity through inhibiting TLR4/NF-κB signaling pathways in lipopolysaccharide-challenged mice.
    Han J; Liu L; Yu N; Chen J; Liu B; Yang D; Shen G
    Anim Sci J; 2016 Aug; 87(8):1011-8. PubMed ID: 26435041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation.
    Lu DX; Liu F; Wu H; Liu HX; Chen BY; Yan J; Lu Y; Sun ZG
    World J Gastroenterol; 2022 Aug; 28(32):4574-4599. PubMed ID: 36157934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of high mobility group box 1 in intestinal mucosal barrier injury in rat with sepsis induced by endotoxin].
    Chen S; Xiu G; Zhou J; Liu P; Chen X; Sun J; Ling B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jul; 32(7):803-807. PubMed ID: 32788013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on anti-inflammatory effect of Shangkehuangshui in vitro and in vivo based on TLR4/TLR2-NF-κB signaling pathway.
    Zhang B; Liang J; Fan H; Lei K; Li H; Liu D; Zheng F; He M; Chen Y
    J Ethnopharmacol; 2024 Apr; 323():117709. PubMed ID: 38181931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of acupuncture on fecal short-chain fatty acids and TLR4/MyD88/NF-κB signaling pathway in spontaneously hypertensive rats].
    Ding Z; Chen T; Zhang L; Jin X; Liu B; Feng X; Zheng J
    Zhongguo Zhen Jiu; 2024 Jun; 44(6):661-8. PubMed ID: 38867628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TLR4/NF-κB in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia.
    Luo H; Guo P; Zhou Q
    PLoS One; 2012; 7(10):e46291. PubMed ID: 23082119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Clostridium perfringens type C on TLR4/MyD88/NF-κB signaling pathway in piglet small intestines.
    Shi H; Huang X; Yan Z; Yang Q; Wang P; Li S; Sun W; Gun S
    Microb Pathog; 2019 Oct; 135():103567. PubMed ID: 31163250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect and Mechanism of Sancao Lichang Decoction on Diarrhea- Predominant Irritable Bowel Syndrome by Regulating Tlr4/Myd88/Nf-Κb Pathway.
    Zhang P; Ma Y; Wang Z; Tang D
    Comb Chem High Throughput Screen; 2023; 26(13):2372-2379. PubMed ID: 36856180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.
    Youssef ME; Abdelrazek HM; Moustafa YM
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):11-31. PubMed ID: 32776158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway.
    Hu N; Wang C; Dai X; Zhou M; Gong L; Yu L; Peng C; Li Y
    J Ethnopharmacol; 2020 Feb; 248():112361. PubMed ID: 31683033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
    Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
    J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexavalent Chromium Exposure Induces Intestinal Barrier Damage
    Xing C; Yang F; Lin Y; Shan J; Yi X; Ali F; Zhu Y; Wang C; Zhang C; Zhuang Y; Cao H; Hu G
    Front Immunol; 2022; 13():952639. PubMed ID: 35935959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.